| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.084 | 0.06 |